A Message From Cure Leukaemia co-founder Professor Charlie Craddock CBE


Cure Leukaemia was established in 2003 to give blood cancer patients rapid access to pioneering drug and transplant treatments by funding a network of specialist research nurses in major leukaemia centres to deliver world-class clinical trials. This highly effective delivery model has transformed the speed at which groundbreaking clinical trials of new drug and transplant therapies can be assessed, and in the process, given patients for whom standard treatments have failed, access to potentially life-saving drugs.


Every £10 donated to Cure Leukaemia can leverage £100 of free, potentially life-saving drugs. Here is Cure Leukaemia Patron Adrian Chiles explaining how this works:
 

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell